Cefepime Hydrochloride; Enmetazobactam Patent Expiration
Cefepime Hydrochloride; Enmetazobactam is used for treating complicated urinary tract infections (CUTI) including pyelonephritis caused by designated susceptible microorganisms. It was first introduced by Allecra Therapeutics Sas
Cefepime Hydrochloride; Enmetazobactam Patents
Given below is the list of patents protecting Cefepime Hydrochloride; Enmetazobactam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Exblifep | US11124526 | Crystalline beta-lactamase inhibitor | Nov 07, 2034 | Allecra Theraps |
| Exblifep | US7687488 | 2-substituted methyl penam derivatives | Dec 03, 2027 | Allecra Theraps |
Cefepime Hydrochloride; Enmetazobactam's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List